Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...

Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's ...

We recently published a list of These 10 Stocks Led Rally on Wednesday. In this article, we are going to take a look at where ...

Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...

On the positive side, CVS is a more diversified healthcare company than Walgreens. CVS isn't just a leading pharmacy chain (which, like Walgreens, also sells some groceries and other items). It is ...

CVS Health (NYSE: CVS) is in the same boat ... So, can it avoid having to suspend its dividend? On the positive side, CVS is a more diversified healthcare company than Walgreens.

CVS Health reported fourth-quarter revenue and profit that topped ... insulin prices Pfizer says drug for deadly cancer ...